Tempus AI/$TEM
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Ticker
$TEM
Sector
Primary listing
Industry
Life Sciences Tools & Services
Headquarters
Employees
2,400
ISIN
US88023B1035
Website
Tempus AI Metrics
BasicAdvanced
$11B
-
-$4.92
-
-
Price and volume
Market cap
$11B
52-week high
$91.45
52-week low
$30.77
Average daily volume
14M
Financial strength
Current ratio
1.706
Quick ratio
1.442
Long term debt to equity
260.069
Total debt to equity
262.957
Interest coverage (TTM)
-12.10%
Profitability
EBITDA (TTM)
-658.21
Gross margin (TTM)
57.09%
Net profit margin (TTM)
-88.27%
Operating margin (TTM)
-87.96%
Effective tax rate (TTM)
6.08%
Revenue per employee (TTM)
$330,000
Management effectiveness
Return on assets (TTM)
-43.89%
Return on equity (TTM)
10,560.77%
Valuation
Price to revenue (TTM)
11.597
Price to book
33.71
Price to tangible book (TTM)
-27.55
Price to free cash flow (TTM)
-43.804
Free cash flow yield (TTM)
-2.28%
Free cash flow per share (TTM)
-145.05%
Growth
Revenue change (TTM)
42.93%
Earnings per share change (TTM)
6.29%
Bulls say / Bears say
Tempus AI's recent multi-year collaboration with AstraZeneca and Pathos AI, valued at $200 million, aims to develop a multimodal foundation model in oncology, potentially enhancing its market position and revenue streams. (Benzinga)
Analysts at BTIG Research initiated coverage on Tempus AI with a 'Buy' rating and a $60.00 price target, indicating confidence in the company's growth prospects. (MarketBeat)
The AI healthcare market is projected to grow by over 30%, positioning Tempus AI to gain significant market share with its AI-enabled precision medicine solutions. (Benzinga)
Tempus AI reported a net loss of $214.1 million in 2023, raising concerns about its path to profitability. (NBC10 Philadelphia)
The company's debt-to-equity ratio stands at 8.31, significantly higher than industry averages, indicating a heavy reliance on borrowed funds and potential financial risk. (Webull)
Insider selling activity, including the CEO's sale of 79,118 shares, may signal a lack of confidence in the company's short-term prospects. (MarketBeat)
Data summarised monthly by Lightyear AI. Last updated on 10 Jun 2025.
Tempus AI News
AllArticlesVideos
Tempus Announces Pricing of Upsized Offering of $650 Million of Convertible Senior Notes
Business Wire·13 hours ago
TEMPUS AI, INC. (NASDAQ: TEM) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Tempus AI, Inc. Investors of Upcoming Deadline
GlobeNewsWire·23 hours ago
Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense
Business Wire·1 day ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Tempus AI stock?
Tempus AI (TEM) has a market cap of $11B as of July 01, 2025.
What is the P/E ratio for Tempus AI stock?
The price to earnings (P/E) ratio for Tempus AI (TEM) stock is 0 as of July 01, 2025.
Does Tempus AI stock pay dividends?
No, Tempus AI (TEM) stock does not pay dividends to its shareholders as of July 01, 2025.
When is the next Tempus AI dividend payment date?
Tempus AI (TEM) stock does not pay dividends to its shareholders.
What is the beta indicator for Tempus AI?
Tempus AI (TEM) does not currently have a Beta indicator.